Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1995-9-19
|
pubmed:abstractText |
Results of clinical trials have indicated that cA2, a neutralizing mouse/human IgG1 chimeric anti-human TNF-alpha monoclonal antibody, may have therapeutic benefit for rheumatoid arthritis patients. Arthritic joints contain, in addition to elevated levels of soluble TNF-alpha, high numbers of CD4+ T cells and macrophages, cells known to express transmembrane TNF-alpha upon activation. For that reason, we sought to determine if cA2 binds to transmembrane TNF-alpha and what effects such binding may have on TNF-alpha-expressing cells. A cell line expressing a cell-surface, mutant form of transmembrane TNF-alpha was prepared for these studies. Analysis of these TNF+ cells by flow cytometry, direct binding, and competitive binding assays showed that cA2 binds to the transmembrane form of TNF-alpha with high avidity. Binding of the IgG1 isotype of cA2, but not an IgG4 version of cA2, resulted in efficient killing of the TNF+ cells by both antibody-dependent cellular toxicity and complement-dependent cytotoxicity effector mechanisms. These findings indicate that, in addition to blocking soluble TNF-alpha activity, cA2 can bind to transmembrane TNF-alpha in vitro and suggest that cA2 binding may lead to lysis of TNF-alpha-expressing cells in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Complement System Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1043-4666
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
251-9
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7640345-Animals,
pubmed-meshheading:7640345-Antibodies, Monoclonal,
pubmed-meshheading:7640345-Antigen-Antibody Reactions,
pubmed-meshheading:7640345-Base Sequence,
pubmed-meshheading:7640345-Complement System Proteins,
pubmed-meshheading:7640345-Cytotoxicity, Immunologic,
pubmed-meshheading:7640345-Humans,
pubmed-meshheading:7640345-Lymphocyte Activation,
pubmed-meshheading:7640345-Membrane Proteins,
pubmed-meshheading:7640345-Mice,
pubmed-meshheading:7640345-Molecular Sequence Data,
pubmed-meshheading:7640345-Recombinant Fusion Proteins,
pubmed-meshheading:7640345-Recombinant Proteins,
pubmed-meshheading:7640345-T-Lymphocytes, Regulatory,
pubmed-meshheading:7640345-Tumor Necrosis Factor-alpha
|
pubmed:year |
1995
|
pubmed:articleTitle |
Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions.
|
pubmed:affiliation |
Department of Molecular Biology, Centocor, Inc., Malvern, PA 19355, USA.
|
pubmed:publicationType |
Journal Article
|